Garrett Temple

Never stopped building

📍 United States🔄 Updated September 2026💼 8 investments📅 2 years investing🗓 Last invested Apr 2026
VC🌍 United StatesInvested this year
8
Total investments
3
Early stage
1
Mid stage
0
Late stage
2y
Years active

Portfolio

7 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Apr 2026
At Cache, we are on a mission to store the biomolecules of today to unlock the possibilities of tomorrow. We believe that nucleic acids are the new bits of the 21st century, so harnessing the information stored in them will help usher in the future of precision medicine and biological computing. Our vision is to create a scalable, sustainable, and standardized platform for reliable storage and access of biomolecules by combining chemistry, biology, automation, and computational tools.
Investor
Apr 2026
AI agents for data science and engineering in bioengineering and beyond.
Investor
Jan 2026
DarkSigma, Inc. builds SigmaNet — a predictive intelligence system that reads the pulse of American innovation. By fusing signals from SBIR programs, patents, funding flows, and talent movement, SigmaNet identifies undervalued technologies and the ventures most likely to define the next industrial era. Its architecture transforms raw innovation data into foresight — revealing where capital, capability, and strategy will converge long before the market does.
Investor
Oct 2025
Teach robots new skills through natural language and run reliably in production in minutes.
Investor
Jul 2024
Anduril is not a traditional defense contractor. We are shaping the future of defense, transforming US & allied military capabilities with advanced technology. We emphasize speed and results and control our products from start to finish, including funding R&D to selling finished products off the shelf. Today, Anduril is in a rapid growth phase, deploying technology in diverse locations and developing path-making products that will change defense forever. We believe that everyone at Anduril can be a catalyst. Your perspective can change lives, and we want to help you make your mark. Our team includes thinkers and doers working interdependently. We bring the brightest minds and best-in-class talent together with veterans who have lived the problems of our warfighters. If you like building quickly and seeing your work deployed in the real world, we want you at Anduril. With offices in Orange County, Washington DC, Seattle, Boston, Atlanta, London, and Sydney, our reach is wide. Check out our careers page at https://www.anduril.com/careers or send us an email at careers@anduril.com.
Investor
Jul 2024
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artificial intelligence benefits all of humanity. AI is an extremely powerful tool that must be created with safety and human needs at its core. OpenAI is dedicated to putting that alignment of interests first — ahead of profit. To achieve our mission, we must encompass and value the many different perspectives, voices, and experiences that form the full spectrum of humanity. Our investment in diversity, equity, and inclusion is ongoing, executed through a wide range of initiatives, and championed and supported by leadership. At OpenAI, we believe artificial intelligence has the potential to help people solve immense global challenges, and we want the upside of AI to be widely shared. Join us in shaping the future of technology.
Investor
Jul 2024
Were an AI research company that builds reliable, interpretable, and steerable AI systems. Our first product is Claude, an AI assistant for tasks at any scale. Our research interests span multiple areas including natural language, human feedback, scaling laws, reinforcement learning, code generation, and interpretability.
Experience · 11 entries
All (11)
Investments (8)
Founder (2)
2026
Investor
Apr 2026
At Cache, we are on a mission to store the biomolecules of today to unlock the possibilities of tomorrow. We believe that nucleic acids are the new bits of the 21st century, so harnessing the information stored in them will help usher in the future of precision medicine and biological computing. Our vision is to create a scalable, sustainable, and standardized platform for reliable storage and access of biomolecules by combining chemistry, biology, automation, and computational tools.
Investor
Apr 2026
AI agents for data science and engineering in bioengineering and beyond.
Co-Founder and General Partner
Jan 2026
Year Zero is a substrate fund—deep tech venture capital with a thesis based on input-layer transformation. We invest in technologies with outsized potential for future downstream development. Our thesis also includes a major emphasis on research commercialization and investing in spinouts—we aim to bridge the lab-to-market gap through capital direction to input-layer technologies with institutional origins. Substrates include: >Energy >Advanced materials >Manufacturing and industrial tech >Robotics >Computing hardware >Biotech >Medicine >Aerospace >Defense tech >R&D tools for all other areas mentioned
Investor
Jan 2026
DarkSigma, Inc. builds SigmaNet — a predictive intelligence system that reads the pulse of American innovation. By fusing signals from SBIR programs, patents, funding flows, and talent movement, SigmaNet identifies undervalued technologies and the ventures most likely to define the next industrial era. Its architecture transforms raw innovation data into foresight — revealing where capital, capability, and strategy will converge long before the market does.
2025
Investor
Oct 2025
Teach robots new skills through natural language and run reliably in production in minutes.
Show all 11 entries ↓
Investment activity
2024–2026 · 8 investments
202442025120263
Recent (last 2 years)Earlier